Overview
High-throughput screening (HTS) is an experimental approach that rapidly tests very large numbers of chemical compounds, biological samples, or genetic perturbations against a defined biological target or assay to identify active candidates. Central to early drug discovery, it uses miniaturised assays in microplate formats, laboratory automation and robotics, sensitive detection systems, and data-analysis pipelines to evaluate thousands to millions of samples efficiently. Assays are designed as readouts of a biological response, such as enzyme activity, receptor binding, gene expression, or cellular signalling, and may be biochemical or cell-based; functional cellular assays, including calcium-transient and other phenotypic measurements in human induced pluripotent stem cell-derived cells, allow screening in physiologically relevant systems. Compounds that produce a desired effect are flagged as hits and progress through confirmation, dose-response characterisation, and counter-screening to remove artefacts and establish selectivity, yielding validated leads for medicinal-chemistry optimisation. HTS complements computational and structure-based methods, with in silico screening and rational design used to focus libraries and prioritise candidates for in vitro and in vivo testing. It is applied to small-molecule discovery, target validation, and the profiling of compound activity and toxicity. As a scalable engine for hit identification, high-throughput screening links library design, assay development, automation, and informatics within modern molecular biology and pharmaceutical research.
Research published in this journal
5 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Proteomic and Genomic Techniques in Medical Research: Applications in Cancer, Diagnostics, and Personalized Medicine
Calcium Transient Assays for Compound Screening with Human iPSC-derived Cardiomyocytes: Evaluating New Tools
A Review on Drug Design by the Application of Computer
Stereoselective Synthesis of N-Glycosyl Oxazolines and Evaluation of Their Antiproliferative Activity
How this research is being cited
The 5 articles above have been cited 32 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2025 · Elsevier eBooks
-
2025 · Journal of New Developments in Chemistry
-
2025 · Journal of new developments in Chemistry
-
Taylor Anglen et al. · 2025 · bioRxiv
-
2024 · Cell stem cell
-
Lara G. Dresser et al. · 2024 · bioRxiv
-
K. Raniga et al. · 2024 · Cell Stem Cell
-
2023 · BMC Cancer
A sample of recent works citing this journal's research on High Throughput Screening, linking to each citing work.